BH4-responsive hyperphenylalaninemia remedies

Details for Australian Patent Application No. 2005239939 (hide)

Owner Daiichi Sankyo Company Limited

Inventors Sugita, Osamu; Matsumoto, Masako; Takai, Tomokazu

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2005239939

PCT Pub. Number WO2005/107759

Priority 2004-141615 11.05.04 JP

Filing date 11 May 2005

Wipo publication date 17 November 2005

Acceptance publication date 27 January 2011

International Classifications

A61K 9/14 (2006.01) Medicinal preparations characterised by special physical form - Particulate form, e.g. powders

A61J 3/02 (2006.01) Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms

A61K 9/10 (2006.01) Medicinal preparations characterised by special physical form - Dispersions

A61K 9/16 (2006.01) Medicinal preparations characterised by special physical form - Agglomerates

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61K 47/02 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Inorganic compounds

A61K 47/20 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - containing sulfur

A61K 47/22 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Heterocyclic compounds

A61P 3/00 (2006.01) Drugs for disorders of the metabolism

Event Publications

23 November 2006 PCT application entered the National Phase

  PCT publication WO2005/107759 Priority application(s): WO2005/107759

24 May 2007 Change of Name(s) of Applicant(s), Section 104

  Daiichi Asubio Pharma Co., Ltd. The name of the applicant has been changed to Asubio Pharma Co., Ltd.

19 August 2010 Alteration of Name

  The name of the applicant has been altered to Daiichi Sankyo Company Limited

27 January 2011 Application Accepted

  Published as AU-B-2005239939

3 March 2011 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 17 Jan 2011. Address for service in Australia - Phillips Ormonde Fitzpatrick 367 Collins Street Melbourne VIC 3000

30 June 2011 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 17 Jan 2011

30 June 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005239948-Delivery system for bioactive agents on the basis of a polymeric drug carrier comprising an amphiphilic block polymer and a polylacticacid derivative

2005239931-Antifatigue composition